DMX-200 recommended for regulatory approval in COVID-19 study in India
Posted 27 September 2021 Highlights DCGI review complete and study formally recommended for regulatory approval Multiple clinical sites in India initiated Study protocol to recruit 600 participants with COVID-19 overall, with a safety analysis conducted after the first…
AdAlta Granted R&D Rebate funding Facility with Invest Victoria
Posted 22 September 2021 AdAlta granted A$4.0m non-dilutive R&D Rebate funding Facility with Invest Victoria. Facility is one of the first of its kind from Victorian Government. Facility relates to FY2022 R&D and is in addition to existing…
Joint Statement of support for an Australian Patent Box
Posted 15 September 2021 See BioMelbourne Network’s submission in response to the Australian Patent Box See Joint Statement on Patent Box Australia’s health innovators support the introduction of a Patent Box, and we welcome this initiative by the…
New Swinburne hub co-creating the medical technologies of the future
Posted: 10 September 2021 MedTechVic will bring people with disabilities together with world-leading technology and expertise to create life-changing new medical and enabling technologies. MedTechVic will create the Australian Assistive Technology Living Facility (LivingAT) on Swinburne’s Hawthorn campus,…
SYNthesis Research announces Chief Innovation Officer
Posted 1 September 2021 SYNthesis Research has announced that Dr Martine Keenan will be joining as Chief Innovation Officer. Martine brings to the role exceptional national and international experience in translational drug discovery & development, and the reputation…
4DMedical partners with Asthma Australia
Posted 1 September 2021 Asthma Australia and BioMelbourne Network member 4DMedical have announced a partnership recognising a mutual commitment to promote awareness and improve diagnostic technology for 2.7 million people living with asthma. Asthma is a life-long respiratory…
Neo-Bionica appoints internationally recognised CEO and Chair
Posted 1 September 2021 Neo-Bionica, a joint venture between Bionics Institute and The University of Melbourne has announced the appointment of two extremely well credentialled individuals. Dr Ludovic Labat has been appointed as CEO while BioMelbourne Network’s own Lusia Guthrie has…
Partnership to develop new drugs for childhood solid tumours
Posted 29 August 2021 BioMelbourne Network member Oncology One has announced a new partnership with Children’s Cancer Institute to develop new drugs for the treatment of childhood solid tumours. The partnership is focused on the development of novel…
Industry survey: Impact of the pandemic on freight and logistics for Victorian Healthtech
Industry survey in partnership between Global Victoria and BioMelbourne Network An opportunity for you to engage and take a short survey to inform our work on a critical issue to the Healthtech Industry Keep informed about the Issues…
BioForum: Future Direction for mRNA Technology meeting recording
Posted 23 August 2021 Thank you to all those who attended our BioForum: Future Direction for mRNA Technology on Tuesday 10 August 2021, sponsored by the State Government of Victoria, in collaboration with mRNA Victoria. For those who…
ANDHealth Receives $19.75M From Medical Research Future Fund
Posted 20 August 2021 ANDHealth, Australia’s leading digital health commercialisation organisation, has today announced it has been successful in securing $19.75M in funding received from the Australian Federal Government under the Medical Research Future Fund (MRFF) Early Stage…
BioAgilytix to purchase Australia-based 360biolabs
Posted 17 August 2021 BioMelbourne Network member, BioAgilytix, a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed a definitive agreement…
